A new therapeutic domain concerns hybrid sequences. These engineered entities integrate segments derived from multiple protein families, allowing for novel pharmacological properties. This approach offers a promising https://chimerapeptides061109.weblognation.com/61978334/chimera-peptides-a-novel-therapeutic-frontier